Clinical Trial Update: A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized trial evaluating HRS-5635 injection alone or with other agents for chronic hepatitis B; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HRS-5635 (HRS-5635)

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: RECRUITING